Hantavirus cases spark surge in pharma and biotech stocks
- Posted on May 11, 2026
- By CNBC
- 0 Views
- 1 min read
Hantavirus cases spark surge in pharma and biotech stocks
The outbreak of Hantavirus on a cruise ship has led to biotech and pharmaceutical stocks surging on reports of firms developing vaccines.